Prismic develops and commercializes novel-based non-addictive prescription drugs for the treatment of inflammation and neurological disorders... Read more
Prismic develops and commercializes novel-based non-addictive prescription drugs for the treatment of inflammation and neurological disorders... Read more
News
Jul 05, 2019
Market Exclusive
Prismic Pharmaceuticals: FSD Pharma Acquires Prismic Pharmaceuticals
Oct 04, 2018
BioPortfolio
Prismic Pharmaceuticals: Prismic Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250
Aug 10, 2018
BioPortfolio
Prismic Pharmaceuticals: Prismic Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09052018 Prices from USD $250
Jun 18, 2018
BioPortfolio
Prismic Pharmaceuticals: Prismic Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250
Dec 28, 2017
BioPortfolio
Prismic Pharmaceuticals: Prismic Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 28112017 Prices from USD $250
Mar 22, 2017
BioPortfolio
Prismic Pharmaceuticals: Prismic Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 21022017 Prices from USD $250
Jul 01, 2015
BIOSPACE
Prismic Pharmaceuticals: <b>Joseph Krivulka</b> And <b>Martin Simonetti</b> Join Board Of Prismic Pharmaceuticals, Inc.
Jul 01, 2015
PR NEWSWIRE
Press Release: Prismic Pharmaceuticals : Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals
Jun 16, 2015
BIOSPACE
Prismic Pharmaceuticals: Morphine Tolerance Significantly Delayed By Prismic Pharmaceuticals, Inc.'s Palmitoylethanolamide
Jun 16, 2015
PR NEWSWIRE
Press Release: Prismic Pharmaceuticals : Morphine Tolerance Significantly Delayed by Prismic's Palmitoylethanolamide
Prismic Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10